A detailed history of Acuitas Investments, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 512,213 shares of CARA stock, worth $179,274. This represents 0.25% of its overall portfolio holdings.

Number of Shares
512,213
Holding current value
$179,274
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.52 - $1.05 $266,350 - $537,823
512,213 New
512,213 $466,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $18.8M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Acuitas Investments, LLC Portfolio

Follow Acuitas Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuitas Investments, LLC with notifications on news.